Clin2
NCT07514780Likely a fitRecruiting

Safety study of JW0061 in healthy adults

Healthy

This is an early-stage safety test of a new drug called JW0061 in people without serious health conditions. Researchers will monitor how your body processes the drug and any side effects that occur.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
104 people
Ages
19 years to 55 years
Study type
Interventional

Who can take part

  • Weigh between 50 kg and 90 kg (110–200 lbs) with a healthy BMI (18.5–29.9)
  • Be in overall good health with no serious medical conditions
  • No history of cancer in the past 5 years
  • No known allergies to JW0061 or its ingredients
  • No significant scalp conditions that could affect safety monitoring
  • Able to give written permission and follow all study instructions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06703710Recruiting· Phase 1
Safety study of a new drug in healthy volunteers

This early-phase study tests a new drug in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.

Seoul
NCT06549309Recruiting· Phase 1
Early safety study of JMKX003801 in healthy adults

This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.

Shanghai, Shanghai Municipality
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT06635226Recruiting· Phase 1
Safety study of ID110521156 in healthy adults

This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.

Seoul
NCT07724431Not yet recruiting· Phase 1
Safety study of CG-0416 in healthy volunteers

This trial tests a new medicine, CG-0416, in healthy people to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.

Melbourne, Victoria
NCT07419698Recruiting· Phase 1
Safety study of JMT206 injection in healthy volunteers

This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.

Beijing, Beijing Municipality

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.